Praxis Precision Medicines held its 2026 Annual Meeting of Stockholders on June 10, 2026. Stockholders elected Gregory Norden, Marcio Souza, and William Young as Class III directors to serve until the 2029 annual meeting. Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Stockholders approved the advisory vote on executive compensation.